These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1949 related articles for article (PubMed ID: 8137264)

  • 21. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
    Thompson EW; Katz D; Shima TB; Wakeling AE; Lippman ME; Dickson RB
    Cancer Res; 1989 Dec; 49(24 Pt 1):6929-34. PubMed ID: 2582435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G; Katzenellenbogen BS
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein.
    Pink JJ; Jiang SY; Fritsch M; Jordan VC
    Cancer Res; 1995 Jun; 55(12):2583-90. PubMed ID: 7780972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiestrogens are pro-apoptotic in normal human breast epithelial cells.
    Somaï S; Chaouat M; Jacob D; Perrot JY; Rostène W; Forgez P; Gompel A
    Int J Cancer; 2003 Jul; 105(5):607-12. PubMed ID: 12740907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K; Banerjee S; Saxena N; Banerjee SK
    Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of antiestrogens on pS2 and cathepsin D mRNA induction in MCF-7 breast cancer cells.
    Rajah TT; Dunn ST; Pento JT
    Anticancer Res; 1996; 16(2):837-42. PubMed ID: 8687138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y; Ballejo G; Murphy LC; Murphy LJ
    Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Leeding KS; Hu XF; DeLuise M; Zalcberg JR; Bach LA
    Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity.
    Dumont JA; Bitonti AJ; Wallace CD; Baumann RJ; Cashman EA; Cross-Doersen DE
    Cell Growth Differ; 1996 Mar; 7(3):351-9. PubMed ID: 8838865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
    Chalbos D; Philips A; Galtier F; Rochefort H
    Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.
    Brünner N; Frandsen TL; Holst-Hansen C; Bei M; Thompson EW; Wakeling AE; Lippman ME; Clarke R
    Cancer Res; 1993 Jul; 53(14):3229-32. PubMed ID: 8324732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
    Murphy CS; Pink JJ; Jordan VC
    Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V; Jensen EV; Knabbe C
    Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J; Kitlen JW; Briand P; Labrie F; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2003 Mar; 84(4):469-78. PubMed ID: 12732292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family.
    Larsen SS; Egeblad M; Jäättelä M; Lykkesfeldt AE
    Breast Cancer Res Treat; 1999 Nov; 58(1):41-56. PubMed ID: 10634517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells.
    Coradini D; Biffi A; Cappelletti V; Di Fronzo G
    Anticancer Res; 1994; 14(3A):1059-64. PubMed ID: 8074450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 98.